首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1703454

玻璃化冷凍市場－全球產業規模、佔有率、趨勢、機會及預測，依樣本（卵母細胞、胚胎、精子）、最終用途、地區及競爭細分，2020-2030 年預測

Vitrification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Specimen (Oocytes, Embryo, Sperm), By End-use, By Region and Competition, 2020-2030F

出版日期: 2025年04月11日 | 出版商:

TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球玻璃化市場價值為 95.3 億美元，預計到 2030 年將達到 221.2 億美元，預測期內年複合成長率(CAGR) 為 15.04%。

市場概覽
預測期	2026-2030
2024年市場規模	95.3億美元
2030年市場規模	221.2億美元
2025-2030 年複合年成長率	15.04%
成長最快的領域	生物樣本庫
最大的市場	北美洲

玻璃化冷凍是一種先進的冷凍保存技術，已在醫藥、生物技術、環境保護等多個行業中獲得了廣泛應用。該過程涉及將液體轉變為不結晶的固體玻璃狀狀態。在冷凍保存中，玻璃化冷凍技術對於在超低溫（通常為 -196°C 或 -321°F）下保存生物樣本（例如細胞、組織和胚胎）特別有效。與傳統的冷凍方法不同，玻璃化冷凍消除了冰晶的形成，從而最大限度地減少了細胞損傷並提高了解凍後的活力。

輔助生殖技術（ART）領域是市場成長的主要驅動力。玻璃化冷凍徹底改變了卵母細胞和胚胎的保存方式，大大提高了體外受精（IVF）程序的成功率。該技術在幹細胞庫和再生醫學中也發揮著至關重要的作用，有助於長期儲存多能幹細胞以用於先進的治療和藥物發現。此外，玻璃化冷凍技術在生物樣本庫中的應用越來越廣泛，它能夠安全、長期地保存對臨床研究至關重要的生物樣本。

新興應用包括器官保存，其中玻璃化有可能延長捐贈器官的活力並改善移植效果。此外，在環境保護方面，該技術也被用於保存瀕危物種的遺傳物質，並透過種子冷凍保存來保護植物的生物多樣性。

關鍵市場促進因素

生物樣本庫和組織工程的發展

主要市場挑戰

玻璃化冷凍技術成本高

主要市場趨勢

技術進步

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 9.53 Billion
Market Size 2030	USD 22.12 Billion
CAGR 2025-2030	15.04%
Fastest Growing Segment	Biobanks
Largest Market	North America

Vitrification, an advanced cryopreservation technique, has gained significant traction across multiple industries, ranging from medicine and biotechnology to environmental conservation. This process involves the transformation of a liquid into a solid glass-like state without crystallization. In cryopreservation, vitrification is particularly effective for preserving biological samples-such as cells, tissues, and embryos-at ultra-low temperatures (typically -196°C or -321°F). Unlike conventional freezing methods, vitrification eliminates the formation of ice crystals, thereby minimizing cellular damage and enhancing post-thaw viability.

The Assisted Reproductive Technology (ART) sector is a primary driver of market growth. Vitrification has revolutionized oocyte and embryo preservation, substantially improving success rates in in vitro fertilization (IVF) procedures. The technique also plays a vital role in stem cell banking and regenerative medicine, facilitating the long-term storage of pluripotent stem cells for use in advanced therapies and drug discovery. Additionally, vitrification is increasingly adopted in biobanking, where it enables the secure, long-term storage of biological specimens critical for clinical research.

Emerging applications include organ preservation, where vitrification holds the potential to extend the viability of donor organs and enhance transplant outcomes. Moreover, in environmental conservation, the technology is being utilized to preserve genetic material from endangered species and to safeguard plant biodiversity through seed cryopreservation.

Key Market Drivers

Growth in Biobanking and Tissue Engineering

The rapid expansion of biobanking and tissue engineering has become a major catalyst for the global vitrification market. Vitrification's ability to preserve biological specimens in a glass-like state at ultra-low temperatures is essential for ensuring the long-term integrity of samples used in both research and clinical settings.

Biobanks, which store a wide range of biological materials-such as DNA, tissues, and cells-play a crucial role in medical research and therapeutic development. According to the World Health Organization (WHO), over 120 biobanks globally held more than 20 million biological samples as of 2023. The increasing demand for reliable preservation methods has positioned vitrification as a preferred technique due to its superior ability to maintain cellular structure and viability over extended periods.

Key Market Challenges

High Cost of Vitrification Technology

Despite its advantages, the high cost associated with vitrification technology presents a significant barrier to market expansion. The process requires advanced equipment, specialized cryoprotectants, and highly skilled personnel, all of which contribute to elevated capital and operational expenditures.

Establishing a vitrification facility necessitates investment in programmable freezers, cryogenic storage systems, and other high-grade materials. Additionally, continuous maintenance-including liquid nitrogen supply, regulatory compliance, and equipment calibration-further inflates operational costs.

Labor costs are also considerable, as embryologists and laboratory technicians must undergo extensive training to handle sensitive biological materials with precision. Any deviation from protocol can compromise the viability of preserved samples, emphasizing the need for highly qualified professionals.

In developing countries or regions with constrained healthcare budgets, the cost of implementing vitrification technologies can be prohibitive. This limits geographic expansion and restricts access to fertility preservation services for lower-income populations-particularly patients undergoing cancer treatment or gender-affirming care.

Moreover, insurance coverage for fertility preservation is often limited or unavailable, placing the financial burden on patients. The high out-of-pocket expenses discourage many from pursuing vitrification, especially when multiple treatment cycles are required. These economic limitations hinder the widespread adoption of vitrification technologies and raise broader concerns about equitable access to advanced reproductive healthcare.

Key Market Trends

Advancements in Technology

Technological innovation continues to reshape the vitrification landscape, particularly in cryopreservation. Traditional freezing methods often resulted in ice crystal formation, leading to cellular damage. New vitrification techniques eliminate this risk, enabling safer and more effective preservation of cells, tissues, and even entire organs. This progress has significant implications for organ transplantation, IVF, and stem cell therapies.

In materials science, the development of enhanced glass-forming substances with improved resistance to thermal shock and greater transparency is facilitating broader application of vitrification in optics, where precision components such as lenses and prisms require high-quality materials.

The pharmaceutical and biotechnology sectors are also embracing vitrification to develop stable and long-lasting formulations for biopharmaceuticals and vaccines. These methods ensure the preservation of drug efficacy during storage and transport-particularly valuable in resource-limited settings.

In the electronics industry, vitrification is being applied to the production of high-performance devices. Technologies like amorphous silicon and other vitrified materials are central to the manufacture of thin-film transistors and liquid crystal displays (LCDs), contributing to more efficient, lightweight, and visually superior electronic products.

These diverse advancements are expanding the scope of vitrification well beyond traditional biological preservation, positioning it as a transformative technology across multiple high-growth industries.

Key Market Players

Vitrolife Inc.
Genea Biomedx inc.
NidaCon International AB
Minitube International
IMV Technologies Group (Cryo Bio System)
The Cooper Companies, Inc. (A CooperSurgical Fertility Company)
FUJIFILM Corporation (FUJIFILM Irvine Scientific)
Biotech, Inc.
Kitazato Corporation
Shenzhen VitaVitro BiotechAGEN N.V.

Report Scope:

In this report, the Global Vitrification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitrification Market, By Specimen:

Oocytes
Embryo
Sperm

Vitrification Market, By End-use:

IVF Clinics
Biobanks

Vitrification Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitrification Market.

Available Customizations:

Global Vitrification market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Vitrification Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Specimen (Oocytes (Devices, Kits & Consumables) ,Embryo (Devices, Kits & Consumables), Sperm)
- 5.2.2. By End-use (IVF Clinics, Biobanks)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. North America Vitrification Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Specimen
- 6.2.2. By End-use
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Vitrification Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Specimen
    - 6.3.1.2.2. By End-use
- 6.3.2. Canada Vitrification Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Specimen
    - 6.3.2.2.2. By End-use
- 6.3.3. Mexico Vitrification Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Specimen
    - 6.3.3.2.2. By End-use

7. Europe Vitrification Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Specimen
- 7.2.2. By End-use
7.3. Europe: Country Analysis
- 7.3.1. Germany Vitrification Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Specimen
    - 7.3.1.2.2. By End-use
- 7.3.2. United Kingdom Vitrification Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Specimen
- 7.3.3. Italy Vitrification Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Specimen
    - 7.3.3.2.2. By End-use
- 7.3.4. France Vitrification Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Specimen
    - 7.3.4.2.2. By End-use
- 7.3.5. Spain Vitrification Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Specimen
    - 7.3.5.2.2. By End-use

8. Asia-Pacific Vitrification Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Specimen
- 8.2.2. By End-use
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Vitrification Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Specimen
    - 8.3.1.2.2. By End-use
- 8.3.2. India Vitrification Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Specimen
    - 8.3.2.2.2. By End-use
- 8.3.3. Japan Vitrification Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Specimen
    - 8.3.3.2.2. By End-use
- 8.3.4. South Korea Vitrification Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Specimen
    - 8.3.4.2.2. By End-use
- 8.3.5. Australia Vitrification Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Specimen
    - 8.3.5.2.2. By End-use

9. South America Vitrification Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Specimen
- 9.2.2. By End-use
9.3. South America: Country Analysis
- 9.3.1. Brazil Vitrification Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Specimen
    - 9.3.1.2.2. By End-use
- 9.3.2. Argentina Vitrification Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Specimen
    - 9.3.2.2.2. By End-use
- 9.3.3. Colombia Vitrification Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Specimen
    - 9.3.3.2.2. By End-use

10. Middle East and Africa Vitrification Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Specimen
- 10.2.2. By End-use
10.3. MEA: Country Analysis
- 10.3.1. South Africa Vitrification Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Specimen
    - 10.3.1.2.2. By End-use
- 10.3.2. Saudi Arabia Vitrification Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Specimen
    - 10.3.2.2.2. By End-use
- 10.3.3. UAE Vitrification Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Specimen
    - 10.3.3.2.2. By End-use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition
12.2. Product Development
12.3. Recent Developments

13. Global Vitrification Market: SWOT Analysis

14. Competitive Landscape

14.1. Vitrolife Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Genea Biomedx inc.
14.3. NidaCon International AB
14.4. Minitube International
14.5. IMV Technologies Group (Cryo Bio System)
14.6. The Cooper Companies, Inc. (A CooperSurgical Fertility Company)
14.7. FUJIFILM Corporation (FUJIFILM Irvine Scientific)
14.8. Biotech, Inc.
14.9. Kitazato Corporation
14.10. Shenzhen VitaVitro BiotechAGEN N.V.